Yüklüyor......
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
BACKGROUND: Exenatide once weekly (QW) is a glucagon-like peptide-1 receptor agonist (GLP-1RA) for the treatment of type 2 diabetes. Safety and tolerability are key considerations in treatment selection. This analysis examines the safety and tolerability profile of exenatide QW, other approved GLP-1...
Kaydedildi:
| Yayımlandı: | Diabetes Metab Syndr Obes |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445788/ https://ncbi.nlm.nih.gov/pubmed/26056482 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S77290 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|